TRCT
SYNH

Tower Research Capital (TRC)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Tower Research Capital (TRC)’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,413
Closed -$355K – 6391
2023
Q2 		$355K Buy
8,413
+1,611
+24% +$65.1K 0.01% 1199
2023
Q1 		$242K Buy
6,802
+4,327
+175% +$157K 0.01% 1258
2022
Q4 		$91K Sell
2,475
-11,945
-83% -$472K ﹤0.01% 1920
2022
Q3 		$680K Buy
14,420
+1,274
+10% +$82.3K 0.01% 910
2022
Q2 		$942K Buy
13,146
+1,813
+16% +$133K 0.02% 728
2022
Q1 		$917K Buy
11,333
+5,636
+99% +$477K 0.01% 828
2021
Q4 		$585K Buy
5,697
+450
+9% +$43.2K 0.01% 1011
2021
Q3 		$459K Sell
5,247
-732
-12% -$66.3K 0.01% 1049
2021
Q2 		$536K Sell
5,979
-10,121
-63% -$855K 0.01% 1132
2021
Q1 		$1.22M Buy
16,100
+10,608
+193% +$800K 0.02% 671
2020
Q4 		$374K Buy
5,492
+2,728
+99% +$170K 0.01% 1226
2020
Q3 		$147K Sell
2,764
-27,689
-91% -$1.65M ﹤0.01% 2836
2020
Q2 		$1.77M Buy
+30,453
New +$1.64M 0.07% 260
2020
Q1 		– Sell
-8,567
Closed -$510K – 4148
2019
Q4 		$510K Buy
8,567
+7,970
+1,335% +$428K 0.04% 259
2019
Q3 		$31K Sell
597
-2,675
-82% -$137K ﹤0.01% 2173
2019
Q2 		$167K Buy
3,272
+1,073
+49% +$50K 0.01% 937
2019
Q1 		$114K Buy
2,199
+587
+36% +$28.5K 0.01% 1382
2018
Q4 		$63K Buy
1,612
+552
+52% +$25.6K ﹤0.01% 1174
2018
Q3 		$55K Sell
1,060
-250
-19% -$12.2K ﹤0.01% 1705
2018
Q2 		$61K Sell
1,310
-408
-24% -$16.9K ﹤0.01% 1738
2018
Q1 		$61K Buy
1,718
+1,028
+149% +$40.3K 0.01% 1570
2017
Q4 		$30K Sell
690
-10,501
-94% -$491K ﹤0.01% 1747
2017
Q3 		$586K Buy
+11,191
New +$624K 0.05% 222
2016
Q3 		– Sell
-52
Closed -$2K – 4668
2016
Q2 		$2K Sell
52
-213
-80% -$9.36K ﹤0.01% 3998
2016
Q1 		$11K Buy
+265
New +$10.9K ﹤0.01% 1895
2015
Q3 		– Sell
-400
Closed -$16K – 4985
2015
Q2 		$16K Sell
400
-2,010
-83% -$69.3K ﹤0.01% 2304
2015
Q1 		$79K Buy
+2,410
New +$66.6K 0.01% 1097

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tower Research Capital (TRC)'s SYNH Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 8,413 shares — an estimated $355K sold.

Tower Research Capital (TRC) first reported a position in SYNH in Q1 2015 and held it in 27 quarters. The position peaked at $1.77M in Q2 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,413 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $355K.
  • Tower Research Capital (TRC) first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 27 quarters.
  • Tower Research Capital (TRC)'s Syneos Health, Inc. Class A Common Stock position peaked at $1.77M in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.